Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 204 for Amyloidosis

Edit search filters
  1. A Study To Evaluate The Effectiveness And Safety Of Vutrisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy

    Rochester, MN

  2. A Study To Evaluate The Effectiveness And Safety Of AKCEA-TTR-LRx In Patients With ATTR CM

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

    Rochester, MN

  4. I-124 Evuzamitide PET/CT Imaging For The Diagnosis Of Cardiac Amyloidosis

    Rochester, MN

  5. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

    Rochester, MN

  6. The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

    Rochester, MN

  7. A Study to Monitor Cardiac Amyloidosis Patients with Implantable Event Monitors

    Rochester, MN

  8. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

    Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate The Effectiveness And Safety Of CAEL-101 In Patients With Mayo Stage IIIa AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

    Rochester, MN

.

Mayo Clinic Footer